Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. - Wikidata - wikimedia - TriplyDB

Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes.

Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes.

http://www.wikidata.org/entity/Q34401659

about

Early invasive versus conservative strategies for unstable angina and non-ST elevation myocardial infarction in the stent era Troponin I is present in human cartilage and inhibits angiogenesis Debate: Unstable angina - When should we intervene?Implications of troponin testing in clinical medicine A new scoring system to stratify risk in unstable angina The role of cardiac troponin I as a prognosticator in critically ill medical patients: a prospective observational cohort study.Cardiac troponins in intensive care.Routine invasive strategies versus selective invasive strategies for unstable angina and non-ST elevation myocardial infarction in the stent era Cardiac Troponins in Dogs and Cats Mass spectrometry for translational proteomics: progress and clinical implications The physiology of cardiovascular disease and innovative liposomal platforms for therapy High-sensitivity troponin assays: evidence, indications, and reasonable use A population-based evaluation of the thrombolysis in myocardial infarction risk score for unstable angina and non-ST elevation myocardial infarction Prospective evaluation of the relationship between platelet-leukocyte conjugate formation and recurrent myocardial ischemia in patients with acute coronary syndromes The British Cardiac Society Working Group definition of myocardial infarction: implications for practice Elevated troponin and myocardial infarction in the intensive care unit: a prospective study.Improving the care of patients with non-ST-elevation acute coronary syndromes in the emergency department: the CRUSADE initiative Coagulation, inflammation and myocardial dysfunction in unstable coronary artery disease and the influence of glycoprotein IIb/IIIa inhibition and low molecular weight heparin Contemporary management of acute coronary syndrome Ischaemic symptoms, quality of care and mortality during myocardial infarction Clinical risk scoring beyond initial troponin values: results from a large, prospective, unselected acute chest pain population Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology Complementary roles for biomarkers of biomechanical strain ST2 and N-terminal prohormone B-type natriuretic peptide in patients with ST-elevation myocardial infarction Postoperative biomarkers predict acute kidney injury and poor outcomes after adult cardiac surgery A Sensitive Cardiac Troponin T Assay in Stable Coronary Artery Disease Acute coronary syndromes: diagnosis and management, part I Clinical, electrocardiographic, and biochemical data for immediate risk stratification in acute coronary syndromes.Do induced tachycardias within the scope of electrophysiological studies lead to elevated plasma troponin I levels?Use of glycoprotein IIb/IIIa inhibitors in unstable angina and non-ST-elevation myocardial infarction.Prevalence and prognostic significance of incidental cardiac troponin T elevation in ambulatory patients with stable coronary artery disease: data from the Heart and Soul study.Cardiac troponin I and troponin T: recent players in the field of myocardial markers.The effect of postoperative myocardial ischemia on long-term survival after vascular surgery.Biomarkers in acute myocardial infarction.Identification of cardiac myosin-binding protein C as a candidate biomarker of myocardial infarction by proteomics analysis Trends in incidence, severity, and outcome of hospitalized myocardial infarction.Clinical criteria replenish high-sensitive troponin and inflammatory markers in the stratification of patients with suspected acute coronary syndrome.Management of unstable angina based on considerations of aetiology Contemporary treatment of unstable angina and non-ST-segment-elevation myocardial infarction (part 1).Biochemical markers in myocardial injury.Regular review: treatment possibilities for unstable angina.

P2860

Q24236794-093CE906-A5B0-4B7D-97EE-A8CF7D12D33E Q24674047-8ACEBB8D-818D-42BC-B44F-31C04D8B976A Q24792327-82E3AE5C-92C5-443D-BD61-E3856C857471 Q24793067-18791D18-DC3D-4F2E-BE4C-EF927AEF7524 Q24799274-E990F716-A929-44D9-8429-F8FB434A2411 Q24810698-7A81982F-3C71-4020-9234-ECD3FD2FED2A Q24810913-8EE15849-0FDB-4E06-A492-DBFC554302EE Q26471900-BC403C64-0749-4FC8-91D1-2E7C8B96482F Q26774969-57322905-83D6-4293-8F76-D305A3BFE137 Q26995497-08233E12-30C8-47A1-A2F3-4486D56A167E Q27002949-5B1E0268-FB80-4425-B52B-ABB38D027ACF Q27007551-C661418C-C781-41FC-BAB2-2E421F6738BA Q28167379-6716BD7D-2CB1-46A0-8A08-2CE46EE3EC83 Q28167462-0E94E43D-4504-4A37-9FBE-D8C5FB7B1DA3 Q28174074-FFBD8465-D383-4686-8DFF-E4ACB81FCBB6 Q28193296-2C0A8D6E-9505-4F7D-B410-4D1CA3358B53 Q28194111-F1655876-D7BB-4BB8-A2ED-7BDF5B338DD0 Q28208874-1F78AD76-3E12-4131-87F8-8FC72B7D07A8 Q28212068-90231C46-C4C0-4A3C-9CA2-595CE9C6A2D0 Q28218595-9D435596-905A-4559-A22E-B982CC3C9751 Q28221349-6C04BE1F-F954-4E30-90A3-E25DA333C620 Q28239975-CC694EBC-A37E-4D94-A6EA-969F3974A9D7 Q28274593-C5E75143-4E87-45B1-B9F9-C7B9DD5336A0 Q28740455-5D51B70A-D977-4CDE-A3F7-A569D6841C0D Q29028464-3809211A-DE34-41CA-A942-7CCB29C43DB2 Q30490718-82AE2B52-7AC3-4B8E-A86D-FA1DA56C4C49 Q30627641-010A648F-8E72-496C-A48A-74573682F073 Q33160728-F4A6BE89-BE19-4273-B1D6-D79640169EEA Q33369310-7FF59BB8-8CAC-46EB-9623-5DBB0495CACE Q33506787-02429056-E26A-4B13-8CB3-FC62C0C14259 Q33545643-1917F520-3331-4190-AD3C-E2C9890FD857 Q33579245-7354FB70-AAE9-441E-AB97-DCBBCAA1ECE6 Q33596823-2A43F773-C825-4411-B819-741D52DBD85B Q33628912-35F888AA-CB55-4361-95E2-F4C31711F8E3 Q33684381-E6409E6E-CDA4-4D52-8737-9AA52E6C4D60 Q33706806-E851DC6E-2C3A-4641-996B-118D5C0E33A8 Q33723966-A5B20754-F19C-4B05-BA25-DA63600472BB Q33776221-4068C3B2-8EDC-463E-B572-3C1491E3E94E Q33778204-B2AD2A65-AE47-4D76-ADE7-8A3001C9A234 Q33802938-B139A5C5-9587-43A1-ACC3-35A65281576C

P2860

Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes.

http://www.wikidata.org/entity/Q34401659

description

1996 nî lūn-bûn

@nan

1996 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

1996 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

1996年の論文

@ja

1996年論文

@yue

1996年論文

@zh-hant

1996年論文

@zh-hk

1996年論文

@zh-mo

1996年論文

@zh-tw

1996年论文

@wuu

name

Cardiac-specific troponin I le ...... with acute coronary syndromes.

@ast

Cardiac-specific troponin I le ...... with acute coronary syndromes.

@en

Cardiac-specific troponin I le ...... with acute coronary syndromes.

@nl

type

label

Cardiac-specific troponin I le ...... with acute coronary syndromes.

@ast

Cardiac-specific troponin I le ...... with acute coronary syndromes.

@en

Cardiac-specific troponin I le ...... with acute coronary syndromes.

@nl

prefLabel

Cardiac-specific troponin I le ...... with acute coronary syndromes.

@ast

Cardiac-specific troponin I le ...... with acute coronary syndromes.

@en

Cardiac-specific troponin I le ...... with acute coronary syndromes.

@nl

P1433

Q34401659-49F15137-C776-4EBF-AC91-03781F823A29

P1476

Q34401659-75C6D11E-6A6E-4380-9D1A-4A70A842F4E1

P2093

Q34401659-2BF8B5C6-B0D3-49AF-B863-329D23D7B236

Q34401659-3572B54D-ABC3-4ED8-924A-A27A780C6ECA

Q34401659-495D2CF6-5832-4391-9ABC-6B81858894BC

Q34401659-8A9D899C-9136-439B-816E-86F930AF0D11

Q34401659-9287DB6D-5ED1-43E6-B6BA-10FF9F5FC11C

Q34401659-A69759A4-BB40-434A-BDC5-6EB2D2ABCF9F

Q34401659-BB6A0366-B0FE-4E89-926B-3363DC3F4904

Q34401659-D7BDDBD7-4801-4A92-85E1-3E26E48606B6

Q34401659-E26EC0B8-6445-4E4A-9D23-37838BE5268F

Q34401659-E4FCEC5A-B7B2-4783-BA9B-489485902849

P304

Q34401659-B07755BC-4F52-49AC-855F-DAD708AFA21A

P31

Q34401659-1D5BB102-1285-447F-8FCD-DBF3BC5567A7

P356

Q34401659-71E39FAD-11FE-4B4E-A5F0-69F9C5A0BDA4

P407

Q34401659-4248067C-1216-4F28-9F17-0E564D9D1AB9

P433

Q34401659-3B39C4CB-9CC7-4B9E-A7EF-E179622743ED

P478

Q34401659-B849EC6B-E968-4463-9646-5A2AB1ADCEC0

P577

Q34401659-90875386-330C-4CAF-8CFD-180089D22794

P698

Q34401659-83F146CA-405C-4A4F-8875-68B4A28C2CF4

P921

Q34401659-931FC69C-26BD-4C76-A02B-A144283B9D3D

P356

NEJM199610313351802

P1433

The New England Journal of Medicine

P1476

Cardiac-specific troponin I le ...... with acute coronary syndromes.

@en

P2093

Antman EM

http://www.w3.org/2001/XMLSchema#string

Braunwald E

http://www.w3.org/2001/XMLSchema#string

Cannon CP

http://www.w3.org/2001/XMLSchema#string

Fischer GA

http://www.w3.org/2001/XMLSchema#string

Fung AY

http://www.w3.org/2001/XMLSchema#string

McCabe CH

http://www.w3.org/2001/XMLSchema#string

Schactman M

http://www.w3.org/2001/XMLSchema#string

Tanasijevic MJ

http://www.w3.org/2001/XMLSchema#string

Thompson B

http://www.w3.org/2001/XMLSchema#string

Thompson C

http://www.w3.org/2001/XMLSchema#string

P304

1342-1349

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJM199610313351802

http://www.w3.org/2001/XMLSchema#string

P407

P433

18

http://www.w3.org/2001/XMLSchema#string

P478

335

http://www.w3.org/2001/XMLSchema#string

P577

1996-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

8857017

http://www.w3.org/2001/XMLSchema#string

P921